Cargando…

Curcumin: a calixarene derivative micelle potentiates anti-breast cancer stem cells effects in xenografted, triple-negative breast cancer mouse models

Triple-negative breast cancer (TNBC) is a heterogeneous and clinically aggressive disease with no approved targeted therapy. Curcumin has shown therapeutic potential against TNBC, but it shows low bioavailability and low efficacy when administered as a free drug. Here we describe a novel vehicle for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei, Li, Lin, Zhang, Xiaofen, Liang, Yuan, Pu, Zhijun, Wang, Lingfeng, Mo, Jingxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241084/ https://www.ncbi.nlm.nih.gov/pubmed/28956452 http://dx.doi.org/10.1080/10717544.2017.1381198

Ejemplares similares

Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts
por: García-Quiroz, Janice, et al.
Publicado: (2019)

Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer
por: Martey, Orleans, et al.
Publicado: (2017)

Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer
por: Greish, Khaled, et al.
Publicado: (2018)

Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles
por: Chen, Rujing, et al.
Publicado: (2021)

Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2014)

Sustained Shugoshin 1 downregulation reduces tumor growth and metastasis in a mouse xenograft tumor model of triple-negative breast cancer
por: Jusino, Shirley, et al.
Publicado: (2023)

Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts
por: Nakayama, Jun, et al.
Publicado: (2022)

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
por: Bharti, Santosh K., et al.
Publicado: (2018)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Martin, Miguel, et al.
Publicado: (2021)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
por: Liao, Ming-juan, et al.
Publicado: (2014)

Molecular Investigation on a Triple Negative Breast Cancer Xenograft Model Exposed to Proton Beams
por: Cammarata, Francesco P., et al.
Publicado: (2020)

Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
por: Saraiva, Sofia M., et al.
Publicado: (2021)

Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer
por: Echeverria, Gloria V., et al.
Publicado: (2023)

Impact of the Pd(2)Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model
por: Carneiro, Tatiana J., et al.
Publicado: (2021)

Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 protein
por: Cheng, Tzu-Chun, et al.
Publicado: (2021)

Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells
por: Zuo, Runan, et al.
Publicado: (2021)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
por: Liu, Jingxin, et al.
Publicado: (2019)

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
por: Rosato, Roberto R., et al.
Publicado: (2018)

Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
por: Johnstone, Cameron N., et al.
Publicado: (2018)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
por: Matossian, Margarite D., et al.
Publicado: (2019)

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
por: Merino, D., et al.
Publicado: (2019)

Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer
por: Powell, Reid T., et al.
Publicado: (2020)

Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
por: Park, Hyung Seok, et al.
Publicado: (2019)

Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

Paclitaxel-loaded phosphonated calixarene nanovesicles as a modular drug delivery platform
por: Mo, Jingxin, et al.
Publicado: (2016)

Characterization of an Amphiphilic Phosphonated Calixarene Carrier Loaded With Carboplatin and Paclitaxel: A Preliminary Study to Treat Colon Cancer in vitro and in vivo
por: Li, Meiying, et al.
Publicado: (2019)

Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer
por: Shindikar, Amol, et al.
Publicado: (2016)

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines
por: Bonaccorsi, Paola Maria, et al.
Publicado: (2019)

Self-Assembly Engineering Nanodrugs Composed of Paclitaxel and Curcumin for the Combined Treatment of Triple Negative Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2021)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023)

Applications of calixarenes in cancer chemotherapy: facts and perspectives
por: Yousaf, Ali, et al.
Publicado: (2015)

Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer
por: Matossian, Margarite D., et al.
Publicado: (2020)

ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer
por: Li, Ziqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bmqhv1rar5ptoglhp58uc12nm8